Company overview Services Business development References Press & events Contact & directions

Cellvax is a service company which provides complete preclinical innovating services allowing to accelerate the drug development process for unmet needs related to severe human diseases, cancer, diabetes, etc...   News Drug Validation Models Other Preclinical Services 07/09/2007  Cellvax awarded by European Program Eureka, Oligoclonics Cellvax was awarded by European Program, Eureka, named "Oligoclonics" with another french partner and three partners in the Netherland. For more information, please visit Eureka web site: www.eureka.be 01/01/2005 BIO-Europe (November, 2008) Cellvax will be participating the meeting BIO-Europe on November 17th - 19th 2008 in Heidelberg, Germany. We will be happy to meet you there in order to discuss our possible collaborations. Tumor models Diabetic models Parkinson diseases Nodule system Angiogenesis models In vivo imaging Biodistribution and pharmacokinetics Toxicity studies Histological analysis

terms of use . sitemap .

© All Right Reserved. ® CELLVAX v2.0 2006. Last update: 28/10/08

Designed by ® ATRAGENE WCMS 4.0